Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:1990904 | ribonucleoprotein complex | 2 | 1 |
Related structures:
AlphaFold database: E9AYD2
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 7 |
GO:0003723 | RNA binding | 4 | 7 |
GO:0005488 | binding | 1 | 7 |
GO:0097159 | organic cyclic compound binding | 2 | 7 |
GO:1901363 | heterocyclic compound binding | 2 | 7 |
GO:0003729 | mRNA binding | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_SKI1_1 | 119 | 123 | PF00082 | 0.346 |
CLV_PCSK_SKI1_1 | 167 | 171 | PF00082 | 0.346 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.713 |
DEG_SCF_TRCP1_1 | 40 | 45 | PF00400 | 0.729 |
DOC_CYCLIN_RxL_1 | 116 | 123 | PF00134 | 0.546 |
DOC_MAPK_gen_1 | 140 | 149 | PF00069 | 0.546 |
DOC_WW_Pin1_4 | 179 | 184 | PF00397 | 0.619 |
LIG_14-3-3_CanoR_1 | 119 | 128 | PF00244 | 0.546 |
LIG_FHA_1 | 200 | 206 | PF00498 | 0.639 |
LIG_FHA_1 | 3 | 9 | PF00498 | 0.577 |
LIG_FHA_2 | 149 | 155 | PF00498 | 0.538 |
LIG_LIR_Nem_3 | 123 | 128 | PF02991 | 0.546 |
LIG_LIR_Nem_3 | 78 | 82 | PF02991 | 0.693 |
LIG_PAM2_1 | 6 | 18 | PF00658 | 0.702 |
LIG_SH2_CRK | 166 | 170 | PF00017 | 0.546 |
LIG_SH2_CRK | 79 | 83 | PF00017 | 0.693 |
LIG_SH3_3 | 11 | 17 | PF00018 | 0.710 |
LIG_SH3_3 | 19 | 25 | PF00018 | 0.719 |
LIG_SH3_3 | 198 | 204 | PF00018 | 0.644 |
LIG_SH3_3 | 66 | 72 | PF00018 | 0.500 |
LIG_TRAF2_1 | 151 | 154 | PF00917 | 0.546 |
MOD_CK1_1 | 138 | 144 | PF00069 | 0.546 |
MOD_CK1_1 | 199 | 205 | PF00069 | 0.645 |
MOD_CK1_1 | 38 | 44 | PF00069 | 0.683 |
MOD_CK1_1 | 65 | 71 | PF00069 | 0.717 |
MOD_CK2_1 | 148 | 154 | PF00069 | 0.538 |
MOD_CK2_1 | 189 | 195 | PF00069 | 0.647 |
MOD_GlcNHglycan | 122 | 125 | PF01048 | 0.313 |
MOD_GlcNHglycan | 17 | 20 | PF01048 | 0.765 |
MOD_GlcNHglycan | 191 | 194 | PF01048 | 0.648 |
MOD_GlcNHglycan | 40 | 43 | PF01048 | 0.784 |
MOD_GlcNHglycan | 64 | 67 | PF01048 | 0.673 |
MOD_GlcNHglycan | 8 | 11 | PF01048 | 0.720 |
MOD_GSK3_1 | 154 | 161 | PF00069 | 0.543 |
MOD_GSK3_1 | 179 | 186 | PF00069 | 0.626 |
MOD_GSK3_1 | 2 | 9 | PF00069 | 0.538 |
MOD_GSK3_1 | 27 | 34 | PF00069 | 0.731 |
MOD_GSK3_1 | 38 | 45 | PF00069 | 0.673 |
MOD_LATS_1 | 29 | 35 | PF00433 | 0.812 |
MOD_N-GLC_1 | 138 | 143 | PF02516 | 0.346 |
MOD_N-GLC_1 | 183 | 188 | PF02516 | 0.629 |
MOD_N-GLC_1 | 6 | 11 | PF02516 | 0.691 |
MOD_N-GLC_1 | 62 | 67 | PF02516 | 0.688 |
MOD_NEK2_1 | 27 | 32 | PF00069 | 0.587 |
MOD_NEK2_1 | 97 | 102 | PF00069 | 0.550 |
MOD_NEK2_2 | 158 | 163 | PF00069 | 0.546 |
MOD_PIKK_1 | 210 | 216 | PF00454 | 0.669 |
MOD_PIKK_1 | 35 | 41 | PF00454 | 0.796 |
MOD_PKB_1 | 165 | 173 | PF00069 | 0.546 |
MOD_Plk_4 | 65 | 71 | PF00069 | 0.670 |
MOD_ProDKin_1 | 179 | 185 | PF00069 | 0.624 |
TRG_ENDOCYTIC_2 | 125 | 128 | PF00928 | 0.546 |
TRG_ENDOCYTIC_2 | 166 | 169 | PF00928 | 0.546 |
TRG_ENDOCYTIC_2 | 79 | 82 | PF00928 | 0.808 |
TRG_ER_diArg_1 | 55 | 58 | PF00400 | 0.704 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I044 | Leptomonas seymouri | 71% | 95% |
A0A3Q8IC83 | Leishmania donovani | 93% | 99% |
A4HF08 | Leishmania braziliensis | 86% | 100% |
A4I287 | Leishmania infantum | 93% | 99% |
Q4Q941 | Leishmania major | 95% | 100% |